CP
LMAT icon

Covenant Partners’s LeMaitre Vascular LMAT Stock Holding History

Covenant Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,843
Closed -$204K – 200
2021
Q3 		$204K Hold
3,843
– – 0.08% 185
2021
Q2 		$234K Buy
+3,843
New +$204K 0.09% 185

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SCA
Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

Covenant Partners's LMAT Position: Q4 2021 in Review

Covenant Partners sold out of LeMaitre Vascular (LMAT) in Q4 2021, closing a stake of 3,843 shares — an estimated $204K sold.

Covenant Partners first reported a position in LMAT in Q2 2021 and held it in 2 quarters. The position peaked at $234K in Q2 2021. 183 funds tracked by Wall St. Rank hold LMAT as of Q4 2021.

  • Covenant Partners reported no remaining LeMaitre Vascular position as of Q4 2021 after selling out during the quarter.
  • Covenant Partners sold 3,843 LeMaitre Vascular shares in Q4 2021, an estimated $204K.
  • Covenant Partners first reported a position in LeMaitre Vascular in Q2 2021 and held it in 2 quarters.
  • Covenant Partners's LeMaitre Vascular position peaked at $234K in Q2 2021.
  • 183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2021.

Based on Covenant Partners's 13F filing for Q4 2021, filed 15 Feb 2022.